Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 6
2004 2
2005 4
2006 5
2007 6
2008 7
2009 6
2010 9
2011 13
2012 7
2013 10
2014 17
2015 11
2016 26
2017 22
2018 16
2019 18
2020 29
2021 49
2022 35
2023 40
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

293 results

Results by year

Filters applied: . Clear all
Page 1
French Society for Biological Psychiatry and Neuropsychopharmacology (AFPBN) guidelines for the management of patients with partially responsive depression and treatment-resistant depression: Update 2024.
Yrondi A, Javelot H, Nobile B, Boudieu L, Aouizerate B, Llorca PM, Charpeaud T, Bennabi D, Lefrere A, Samalin L. Yrondi A, et al. Among authors: llorca pm. Encephale. 2024 Feb 17:S0013-7006(24)00019-8. doi: 10.1016/j.encep.2023.11.029. Online ahead of print. Encephale. 2024. PMID: 38369426
[Prescribing and monitoring psychotropic drugs].
Garnier M, Llorca PM, Patoz MC. Garnier M, et al. Among authors: llorca pm. Rev Prat. 2024 Jan;74(1):89-99. Rev Prat. 2024. PMID: 38329262 French. No abstract available.
Evaluating the efficacy and safety of the currently available once-every-two months long-acting injectable formulations of aripiprazole for the treatment of schizophrenia or as a maintenance monotherapy for bipolar I disorder in adults.
Samalin L, Boudieu L, Llorca PM. Samalin L, et al. Among authors: llorca pm. Expert Rev Neurother. 2024 Mar;24(3):291-298. doi: 10.1080/14737175.2024.2313550. Epub 2024 Feb 5. Expert Rev Neurother. 2024. PMID: 38299536 Review.
Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI study.
D'Andrea G, Quattrone D, Malone K, Tripoli G, Trotta G, Spinazzola E, Gayer-Anderson C, Jongsma HE, Sideli L, Stilo SA, La Cascia C, Ferraro L, Lasalvia A, Tosato S, Tortelli A, Velthorst E, de Haan L, Llorca PM, Rossi Menezes P, Santos JL, Arrojo M, Bobes J, Sanjuán J, Bernardo M, Arango C, Kirkbride JB, Jones PB, Rutten BP, Van Os J, Selten JP, Vassos E, Schürhoff F, Szöke A, Pignon B, O'Donovan M, Richards A, Morgan C, Di Forti M, Tarricone I, Murray RM. D'Andrea G, et al. Among authors: llorca pm. Psychol Med. 2024 Jan 30:1-14. doi: 10.1017/S0033291723003781. Online ahead of print. Psychol Med. 2024. PMID: 38288603
Clinical and cognitive characteristics of subjects with schizophrenia and childhood attention-deficit/hyperactivity disorder: Results from the multicentric FACE-SZ cross-sectional dataset.
Dondé C, Coulon N, Turbé H, Andre M, Boyer L, Capdevielle D, Chereau I, Dassing R, Dorey JM, Dubertret C, Leignier S, Llorca PM, Misdrahi D, Passerieux C, Pignon B, Rey R, Schorr B, Schürhoff F, Urbach M, Fond G, Mallet J. Dondé C, et al. Among authors: llorca pm. Schizophr Res. 2024 Feb;264:105-112. doi: 10.1016/j.schres.2023.12.010. Epub 2023 Dec 20. Schizophr Res. 2024. PMID: 38128341
293 results